logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria

Avong YK, Isaakidis P, Hinderaker SG, Van der Bergh R, Ali E, Obembe B, Ekong E, Adebamowo C, Ndembi N, Okuma J, Osakwe A, Oladimeji O, Akang G, Obasanya J, Eltayeb O, Agbaje A, Abimiku A, Mensah C, Dakum P
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Adverse events (AEs) of second line anti-tuberculosis drugs (SLDs) are relatively well documented. However, the actual burden has rarely been described in detail in programmatic settings. We investigated the occurrence of these events in the national cohort of multidrug-resistant tuberculosis (MDR-TB) patients in Nigeria.

Countries

Nigeria

Subject Area

antibiotic resistancetuberculosisantimicrobial resistance

Languages

English
DOI
10.1371/journal.pone.0120161
Published Date
17 Mar 2015
PubMed ID
25781958
Journal
PLOS One
Volume | Issue | Pages
Volume 10, Issue 3
Issue Date
2015-03-17
Dimensions Badge